How long does the cervical cancer vaccine last?

The protection time of cervical cancer vaccination is usually more than 10 years, and the specific duration is related to factors such as vaccine type and individual immune response. There are three main types of HPV vaccines currently on the market: bivalent, quadrivalent and nine-valent, all of which can provide long-term immune protection.

The bivalent HPV vaccine mainly targets HPV types 16 and 18. Studies have shown that antibody levels can be maintained for more than 10 years after vaccination, and the protective effect against cervical precancerous lesions remains stable. In addition to preventing HPV types 16 and 18, the quadrivalent HPV vaccine can also prevent genital warts caused by HPV types 6 and 11. Clinical data shows that its protective efficacy is maintained for at least 10 years. The nine-valent HPV vaccine covers more high-risk HPV types, and existing follow-up data shows that effective antibody titers can still be detected 8-10 years after vaccination. Vaccine-induced immune memory responses may continue to provide protection after antibody levels decline, but it is important to note that the protective effect may gradually weaken over time.

After receiving the HPV vaccine, you still need to undergo regular cervical cancer screening. The vaccine cannot prevent all high-risk HPV infections and has no therapeutic effect on existing HPV infections. It is recommended that women over the age of 21 undergo cervical cytology examination every three years, and women over the age of 30 can undergo combined HPV testing. Maintaining a single sexual partner and using condoms can help reduce the risk of HPV infection. A balanced diet, regular work and rest, and moderate exercise can help maintain immune function. If symptoms such as abnormal vaginal bleeding or increased discharge occur, you should seek medical attention promptly.